Literature DB >> 2904401

Use of restriction fragment length polymorphic probes in the analysis of Down's syndrome trisomy.

A M Millington-Ward1, P L Pearson.   

Abstract

Restriction fragment length polymorphic probes are being used more frequently in the molecular analysis of Down's syndrome and in the origin of nondisjunction in the syndrome. The type of information gained from RFLPs overlaps but differs from the information from cytogenetic heteromorphisms. From the allele frequencies of commonly available probes we have derived the expected frequencies of all matings in the population. Each mating has been defined and partitioned to show the genotypes and phenotypes expected, with numerical values based on studies with heteromorphisms. From this we show how the various phenotypes can be used to calculate the origin of nondisjunctions and their expected frequencies. Further, an alternative method is outlined for mapping the distance between a probe and its centromere based on the distortion, caused by crossing-over, of the expected 1st to 2nd division nondisjunction ratio. Finally, we discuss prospects for various uses of probes in the analysis of Down's syndrome.

Mesh:

Substances:

Year:  1988        PMID: 2904401     DOI: 10.1007/BF00273652

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Centrometric linkage in autosomal trisomies.

Authors:  G B Côté; J H Edwards
Journal:  Ann Hum Genet       Date:  1975-07       Impact factor: 1.670

2.  Reduced recombination rate on chromosomes 21 that have undergone nondisjunction.

Authors:  S E Antonarakis; A Chakravarti; A C Warren; S A Slaugenhaupt; C Wong; S L Halloran; C Metaxotou
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

Review 3.  DNA polymorphism and human disease.

Authors:  J F Gusella
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Presenile dementia and Alzheimer's disease in mongolism.

Authors:  M I Olson; C M Shaw
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

5.  Report of the Committee on Human Gene Mapping by Recombinant DNA Techniques.

Authors:  H F Willard; M H Skolnick; P L Pearson; J L Mandel
Journal:  Cytogenet Cell Genet       Date:  1985

6.  Trisomy 21 in man due to maternal non-disjunction during the first meiotic division.

Authors:  G Licznerski; J Lindsten
Journal:  Hereditas       Date:  1972       Impact factor: 3.271

7.  Down Syndrome and acute leukaemia: increased risk may be due to trisomy 21.

Authors:  J D Rowley
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

Review 8.  Genetic mapping in chromosome 21 and its implications for Down's syndrome and other diseases.

Authors:  D Patterson
Journal:  Somat Cell Mol Genet       Date:  1987-07

9.  Origin of human trisomics and polyploids.

Authors:  P A Jacobs; N E Morton
Journal:  Hum Hered       Date:  1977       Impact factor: 0.444

10.  Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976.

Authors:  T Scholl; Z Stein; H Hansen
Journal:  Dev Med Child Neurol       Date:  1982-12       Impact factor: 5.449

View more
  4 in total

1.  Comparative study of microsatellite and cytogenetic markers for detecting the origin of the nondisjoined chromosome 21 in Down syndrome.

Authors:  M B Peterson; M Frantzen; S E Antonarakis; A C Warren; C Van Broeckhoven; A Chakravarti; T K Cox; C Lund; B Olsen; H Poulsen
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

2.  A contiguous Not I restriction map of band q22.3 of human chromosome 21.

Authors:  D Wang; H Fang; C R Cantor; C L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Coincident maternal meiotic nondisjunction of chromosomes X and 21 without evidence of autosomal asynapsis.

Authors:  R S Ikonen; M Lindlöf; M O Janas; K O Simola; A Millington-Ward; A de la Chapelle
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

4.  Identification of chromosome 21 DNA polymorphisms for genetic studies in Alzheimer's disease and Down syndrome.

Authors:  G Van Camp; H Backhovens; M Cruts; A Wehnert; W Van Hul; P Stinissen; C Van Broeckhoven
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.